La maladie de Parkinson en France (serveur d'exploration) - Analysis (USA)

Index « Auteurs » - entrée « Regina Katzenschlager »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Regina Grazuleviciene < Regina Katzenschlager < Regine Kraft  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000324 (2012) Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Günther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis]Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study
000358 (2011) Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Wearing‐off scales in Parkinson's disease: Critique and recommendations
000362 (2011) Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
000363 (2011) Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
000451 (2010) Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Nervous system diseases
4Parkinson disease
4Parkinson's disease
2Safety
2dopamine agonists
2evidence‐based medicine
1AMPA receptor
1AMPA receptor antagonist
1Acupuncture
1Adult
1Advanced stage
1Aged
1Aged, 80 and over
1Amantadine
1Amine oxidase (flavin-containing)
1Analysis of Variance
1Cholinesterase
1Cholinesterase Inhibitors (therapeutic use)
1Clozapine
1Cognition
1Deep brain stimulation
1Dementia
1Dementia (complications)
1Dementia (drug therapy)
1Donepezil
1Dopamine agonist
1Dose-Response Relationship, Drug
1Double blind study
1Double-Blind Method
1Dyskinesia
1Europe
1Evidence-based medicine
1Executive function
1Female
1Fluctuations
1Humans
1Indans (therapeutic use)
1Levodopa
1Male
1Middle Aged
1Motor system disorder
1Parkinson Disease (complications)
1Parkinson Disease (drug therapy)
1Perampanel
1Physical exercise
1Piperidines (therapeutic use)
1Placebo
1Psychiatric Status Rating Scales
1Psychometrics
1Recommendation
1Reliability
1Speech
1Transferases
1Treatment
1Validity
1acupuncture
1amantadine
1anticholinergics
1catechol‐O‐methyl transferase inhibitors
1cholinesterase inhibition
1clinimetrics
1clozapine
1cognition
1deep brain stimulation
1dementia
1dyskinesia
1executive function
1exercise
1levodopa
1monoamine oxidase inhibitors
1motor fluctuations
1neurosurgery
1occupational therapy
1omega‐3 fatty‐acids
1perampanel
1physical therapy
1psychometrics
1rating scales
1reliability
1selective serotonin reuptake inhibitors (SSRIs)
1speech therapy
1transcranial magnetic stimulation
1tricyclic antidepressants
1validity
1wearing‐off

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/USA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i -k "Regina Katzenschlager" 
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i  \
                -Sk "Regina Katzenschlager" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/USA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    USA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Regina Katzenschlager
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024